Company profile
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. is an Egypt-based pharmaceutical manufacturer specialising in the production, marketing, sale and storage of pharmaceutical products and diagnostic reagents for human and veterinary use. Established in 1986 and headquartered in Sixth of October City, Egypt, the company manufactures branded generic medicines, nutraceuticals and food supplements across therapeutic areas including alimentary tract and metabolism, systemic anti-infectives, musculo-skeletal system, nervous system and cardiovascular products. Rameda operates through private sales, tenders, exports and toll manufacturing, supplying domestic distributors, government-owned institutions and export agents. The company is listed on the Egyptian Exchange under ticker RMDA.
- Sector
- Healthcare / Medical Supplies, Pharmaceuticals
- Markets
- Egypt
- Founded
- 1986
- Ownership
- Public
- Stage
- Corporate
- Capital raised
- $21.7m
- Employees
- 500+
- Business model
- B2B Manufacturing
Products and services
Omnevora, Lacteol Fort, Protofix, Colona, Private-Sale Pharmaceuticals, Tender Pharmaceuticals & Toll Manufacturing Services
Transactions
| Date | Transaction | Type | Value | Market |
|---|---|---|---|---|
| 4 Jun 2026 | LVP Pharma invests in Rameda's operations in Egypt for EGP 1.14 billion | Private Equity | $21.7m | Egypt |
Source: Partner Researchers.